ישראל - עברית - Ministry of Health

comex ltd - procaine benzylpenicillin - תרחיף להזרקה - procaine benzylpenicillin 300 mg/ml

ישראל - עברית - Ministry of Health

comex ltd - dihydrostreptomycin sulfate; procaine benzylpenicillin - תרחיף להזרקה - procaine benzylpenicillin 200 mg/ml; dihydrostreptomycin sulfate 250 mg/ml

ישראל - עברית - Ministry of Health

intervet ( israel) ltd - dihydrostreptomycin as sulfate; nafcillin as sodium; procaine benzylpenicillin - משחה - procaine benzylpenicillin 300 mg / 3 g; dihydrostreptomycin as sulfate 100 mg / 3 g; nafcillin as sodium 100 mg / 3 g

ישראל - עברית - Ministry of Health

intervet ( israel) ltd - dihydrostreptomycin sulfate; nafcillin as nafcillin sodium; procaine benzylpenicillin - משחה - procaine benzylpenicillin 300 mg / 3 g; dihydrostreptomycin sulfate 100 mg / 3 g; nafcillin as nafcillin sodium 100 mg / 3 g

ישראל - עברית - Ministry of Health

novartis israel ltd - fulvestrant - תמיסה להזרקה - fulvestrant 50 mg/ml - fulvestrant

ישראל - עברית - Ministry of Health

j-c health care ltd - miconazole - ג'ל - miconazole 20 mg/g - miconazole - miconazole - oral mycosis (thrush) and fungal infections of the upper gastrointestinal tract. daktarin oral gel can be used for the prevention of oral thrush in patient receiving long-term treatment with antibiotics, steroids, cytotoxic and radiation therapy.

ישראל - עברית - Ministry of Health

astra zeneca (israel) ltd - fulvestrant - תמיסה להזרקה - fulvestrant 250 mg / 5 ml - fulvestrant - fulvestrant - faslodex is indicated for the treatment of postmenopausal women with oestrogen receptor positive, locally advanced or metastatic breast cancer for disease relapse on or after adjuvant antioestrogen therapy or disease progression on therapy with an antioestrogen.

ישראל - עברית - Ministry of Health

astra zeneca (israel) ltd - fulvestrant - תמיסה להזרקה - fulvestrant 250 mg / 5 ml - fulvestrant - fulvestrant - faslodex is indicated for the treatment of postmenopausal women with oestrogen receptor positive, locally advanced or metastatic breast cancer for disease relapse on or after adjuvant antioestrogen therapy or disease progression on therapy with an antioestrogen.06/06/2010 בקשה לשינוי משטר מינון the recommended dose is 500 mg at intervals of one month, with an additional 500 mg dose given two weeks after the initial dose.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - fulvestrant - תמיסה להזרקה - fulvestrant 250 mg / 5 ml - fulvestrant - fulvestrant - faslodex is indicated for the treatment of postmenopausal women with oestrogen receptor positive, locally advanced or metastatic breast cancer for disease relapse on or after adjuvant antioestrogen therapy or disease progression on therapy with an antioestrogen.

ישראל - עברית - Ministry of Health

teva israel ltd - fulvestrant - תמיסה להזרקה - fulvestrant 50 mg/ml - fulvestrant